Program

99
92
5
3
2
1
1

Journal Year Published

3
12
16
11
20
10
8
9
10
12
12
10
12
4

Author

149
201
181
139
133
133
125
123
108
105
95
82
78
63
62
54
50
46
43
43

Category

75
47
31
25
6
5
2
2
2
1
1

Keyword

58
43
32
19
18
16
15
15
14
13
13
12
12
12
11
11
10
10
10
9

Journal

16
13
12
5
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2

NCATS Publications

EWS-FLI1-regulated serine synthesis and exogenous serine are necessary for Ewing sarcoma cellular proliferation and tumor growth.


Issaq SH, Mendoza A, Kidner R, Rosales TI, Duveau D, Heske CM, Rohde JM, Boxer MB, Thomas C, DeBerardinis RJ, Helman LJ


Mol. Cancer Ther. , 2020.

Article Pubmed

Sample image from publication page

Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.


Wei D, Yang Y, Ricketts CJ, Vocke CD, Ball M, Sourbier C, Wangsa D, Wangsa D, Guha R, Zhang X, Wilson K, Chen L, Meltzer PS, Ried T, Thomas C, Merino MJ, Linehan WM


Genes Chromosomes Cancer , 2020.

Article Pubmed

Targeting AML-associated FLT3 mutations with a type I kinase inhibitor.


Jones LM, Melgar K, Bolanos L, Hueneman K, Walker MM, Jiang J, Wilson K, Zhang X, Shen J, Jiang F, Sutter P, Wang A, Xu X, Tawa G, Hoyt S, Wunderlich M, O'Brien E, Perentesis JP, Starczynowski DT, Thomas C


J. Clin. Invest. , (130), 2017-2023, 2020.

Article Pubmed

Sample image from publication page

JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis.


Vian L, Le MT, Gazaniga N, Kieltyka J, Liu C, Pietropaolo G, Dell'Orso S, Brooks SR, Furumoto Y, Thomas C, O'Shea JJ, Sciumè G, Gadina M


Front Immunol , (10), 2972, 2019.

Article Pubmed

Sample image from publication page

Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.


Lin GL, et al.


Sci Transl Med , (11), 2019.

Article Pubmed

Sample image from publication page

eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma.


Chan K, Robert F, Oertlin C, Kapeller-Libermann D, Avizonis D, Gutierrez J, Handly-Santana A, Doubrovin M, Park J, Schoepfer C, Da Silva B, Yao M, Gorton F, Shi J, Thomas C, Brown LE, Porco JA, Pollak M, Larsson O, Pelletier J, Chio IIC


Nat Commun , (10), 5151, 2019.

Article Pubmed

Sample image from publication page

Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors.


Kaur S, Schwartz AL, Jordan DG, Soto-Pantoja DR, Kuo B, Elkahloun AG, Mathews Griner L, Thomas C, Ferrer-Alegre M, Thomas A, Tang SW, Rajapakse VN, Pommier Y, Roberts DD


Front Oncol , (9), 994, 2019.

Article Pubmed

Sample image from publication page

Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets.


Vootukuri S, Li J, Nedelman M, Thomas C, Jiang J, Babayeva M, Coller BS


J Clin Transl Sci , (3), 65-74, 2019.

Article Pubmed

Sample image from publication page

Targeting of Fumarate Hydratase from Mycobacterium tuberculosis Using Allosteric Inhibitors with a Dimeric-Binding Mode.


Whitehouse AJ, Libardo MDJ, Kasbekar M, Brear PD, Fischer G, Thomas C, Barry CE, Boshoff HIM, Coyne AG, Abell C


J. Med. Chem. , 2019.

Article Pubmed

Sample image from publication page

Overcoming adaptive therapy resistance in AML by targeting immune response pathways.


Melgar K, Walker MM, Jones LM, Bolanos LC, Hueneman K, Wunderlich M, Jiang J, Wilson K, Zhang X, Sutter P, Wang A, Xu X, Choi K, Tawa G, Lorimer D, Abendroth J, O'Brien E, Hoyt S, Berman E, Famulare CA, Mulloy JC, Levine RL, Perentesis JP, Thomas C, Starczynowski DT


Sci Transl Med , (11), 2019.

Article Pubmed

Sample image from publication page